The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.


Professor Ebbe Nordlander from the Division of Chemical Physics, Department of Chemistry, Faculty of Natural Sciences, Lund University and PhD Candidate Shafqat Ahmad, from the Genetic and Molecular Epidemiology (GAME) Unit at the Department of Clinical Sciences, Faculty of Medicine, Lund University were granted the one month position in 2015.

Ebbe Nordlander plan was to write a research application to the Swedish Research Council for a project to be developed in collaboration with Associate Professor Tapan Kanti Paine at the Indian Association for the Cultivation of Science in Kolkata, India. The project relates to the development of new metal complexes that can act as catalysts for reactions in which hydrocarbons obtained one or more oxygen atoms (a catalyst is a substance or compound that can accelerate a chemical reaction without itself consumed in the reaction).

Shafqat Ahmed, who was in the final phase of his PhD thesis work, planed to write an application for a coming post-doc project in collaboration with researchers in Pakistan. His research focuses on biological, clinical and lifestyle risk factors in the development of obesity, diabetes and cardiovascular disease in rural Pakistan. The overall purpose is to assess the biological, clinical biomarkers and lifestyle risk factors in the development of type 2 diabetes mellitus (T2DM), cardiovascular diseases (CVD) and related diseases. The project also aims to identify the ways by which knowledge of the disease might help optimize preventive and/or treatment strategies in Pakistani rural population. The overarching goal to lessen personal suffering and burden of these diseases around the world. Research applications will be sent to different agencies in Sweden and Europe, including the Swedish Research Council (VR), Swedish Society of Medical Research, and Wellcome Trust in UK.